Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Clinical trial NCT05282901 · COMPLETED

Trial details

NCT number: NCT05282901
Sponsor: Institut Curie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma

Start date: 2022-07-07
Primary completion: 2025-04-28
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.